GRC Genuine Research Center

GRC Genuine Research Center GRC Genuine Research Center is first Egyptian Full Services Contract Research Organization CRO

GRC Genuine Research Center is an industry leading contract research organization specializing in pharmaceutical drug development, conducing both:
•In-vivo studies: Bioequivalence & Clinical Trials.
• In-vitro studies: comparative in-vitro dissolution & stability.

Www.grc-me.comReview our new website𝑭𝒐𝒍𝒍𝒐𝒘𝒆𝒓𝒔.Egyptian Pharmacists Societyهيئة الدواء المصرية Egyptian Drug Authority
02/07/2025

Www.grc-me.com
Review our new website

𝑭𝒐𝒍𝒍𝒐𝒘𝒆𝒓𝒔.
Egyptian Pharmacists Society
هيئة الدواء المصرية Egyptian Drug Authority

Biowaiver studies Genuine Research Center Established in 2007, GRC is Egypt’s premier stakeholder and full-service contract research organization (CRO). The company specializes in Bioequivalence,

28/02/2025
خبر عظيم حصول هيئة الدواء المصرية علي الإعتماد الدولي من الWHOالمستوي الثالث ألف مبروك لمصر
21/12/2024

خبر عظيم
حصول هيئة الدواء المصرية علي الإعتماد الدولي من الWHO
المستوي الثالث ألف مبروك لمصر

Clinical trials are essential for developing new treatments and ensuring their safety and effectiveness. Here's an overv...
01/10/2024

Clinical trials are essential for developing new treatments and ensuring their safety and effectiveness. Here's an overview of the key stages involved:

1. Preclinical Research
Before any clinical trials can begin, extensive laboratory research and animal studies are conducted. This phase is crucial for assessing the potential efficacy and safety of a new treatment and identifying promising candidates that are safe enough to be tested in humans.

2. Designing the Trial
Protocol Development: Researchers create a detailed plan (protocol) outlining the study's objectives, methodology, eligibility criteria, duration, and endpoints.

Regulatory Approval: The protocol is reviewed and approved by regulatory bodies (e.g., the FDA in the United States) and ethics committees (Institutional Review Boards, or IRBs) to ensure the study is ethical and the rights and safety of participants are protected.

3. Phases of Clinical Trials
Clinical trials are conducted in several phases, each with a specific purpose:

Phase I: Tests the treatment in a small group of people (20-80) to evaluate safety, determine safe dosage ranges, and identify side effects.

Phase II: Expands the study to a larger group (100-300) to determine effectiveness and further evaluate safety.

Phase III: Involves a larger group of people (1,000-3,000) to confirm effectiveness, monitor side effects, compare with standard treatments, and collect information to ensure safe use.

Phase IV: Conducted after the treatment has been approved for use by regulatory agencies to monitor long-term effects, effectiveness in various populations, and any other emerging issues.

4. Recruitment and Participation
Eligibility Criteria: Participants are selected based on specific criteria related to age, gender, type and stage of disease, previous treatment history, and other medical conditions.

Informed Consent: Potential participants are given detailed information about the trial, including its purpose, procedures, risks, benefits, and their rights. They must sign an informed consent form before joining the study.

5. Publication and Approval
Positive trial results are published in scientific journals. Regulatory authorities review the data for approval and decide if the treatment can be used more widely.

6. Post-Market Surveillance
After approval, ongoing monitoring for safety and efficacy occurs in a larger population, with reported adverse events and additional research on long-

تنعى مركز  GRC أ.د / عماد بساليوس الأستاذ بقسم الصيدلانيات و رئيس مركز ARC
24/05/2024

تنعى مركز GRC أ.د / عماد بساليوس الأستاذ بقسم الصيدلانيات و رئيس مركز ARC

أحبائي وأصدقائي، أرسل لكم أطيب التهاني بمناسبة “عيد القيامة”
04/05/2024

أحبائي وأصدقائي، أرسل لكم أطيب التهاني بمناسبة “عيد القيامة”

01/01/2024

٢٠٢٤/١/١
اللهم اجعلة بداية كل فرح و نهاية كل حزن
اللهم استودعك ايامى القادمة فأسترنا و ارحمنا و ارزقنا و بارك لنا فى ابناءنا
بفضلك يا الله 🤲

GRC (Genuine Research Center) is honored to announce that has been accredited by the Iraq Ministry of Health to conduct ...
26/10/2023

GRC (Genuine Research Center) is honored to announce that has been accredited by the Iraq Ministry of Health to conduct bioequivalence studies in Iraq. GRC passed the inspection visit and ensuring that the CRO has strict adherence to international standards of GCP good clinical practices and GLPgood laboratory practices.

31/08/2023

Services offered:
1- Drug Master File (DMF) review
2- Common Technical Document (CTD) report

1- DMF review:
Deliverables:
- Comment sheet categorized into Critical, Major and Minor comments to be sent to API manufacturer.
- Support on the replies received from API manufacturer
Required documents:
- Drug Master File (DMF) for raw material
Time for delivery:
- One week from receiving documents

2- CTD report:
Deliverables:
- For Egypt: CTD Quality Module (3.2.P, 3.2.S, 3.2.R, 3.2.A)
- For International markets: CTD modules (Module 2, 3 , 4 & 5)
Required documents:
- The target countries
- For API:
o Drug Master File (DMF) for raw material.
o Certificate of analysis of API from the supplier (containing any special requirements like Particle size or polymorphism)
o Elemental impurities risk assessment
o Nitrosamine risk assessment (for international markets)
- For Finished Product:
o Name of the manufacturing company
o Name of the license holder
o Product composition
o Finished product specifications and Method of analysis (chemical and microbiological)
o Validation of Method of analysis (and chromatograms)
o Bioequivalence study or In-vitro dissolution
o Product development trials (if available)
o Batch record (pilot batch or commercial batch) and In-process controls
o Process validation protocol and report (if available)
o Certificates of analysis for Excipients (COA of supplier and COA of the finished product manufacturer)
o Certificates of analysis for pilot batches or commercial batches
o Reference or working standard certificates
o Certificates of analysis of packaging materials (PVC, PVDC, Aluminum foil, ALU/ALU) from both the supplier and finished product manufacturer.
o Stability study
o Additional requirements for Egypt:
▪ Inspector attendance notice for pilot batch
▪ Inspector withdrawal notice for pilot batch
▪ Stamped composition
Time for delivery:
Two weeks from receiving documents
Contact: info@grc-me.com

Address

50 El-khaleifa El-Maamon Street Heliopolis
Cairo
TELE:+20224514526

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Sunday 9am - 5pm

Telephone

+20224514516

Alerts

Be the first to know and let us send you an email when GRC Genuine Research Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to GRC Genuine Research Center:

Share

Category